@article{8c663811fb2f46e6b3b14913ca971f1f,
title = "Polarization diversity of human CD4+ stem cell memory T cells",
abstract = "T cells are considered to develop through three stages, from na{\"i}ve T (Tn) into central memory T (Tcm) and finally into effector memory T (Tem). Among the subsets of Tn, stem cell memory T (Tscm) were recently found to be the least developed memory subset. While this subset was revealed to possess self-reproducibility and multipotentiality, little is known about the relationship between development and polarity. We conducted transcriptome analysis of human CD4+ T subsets and found that Tscm was a clearly distinct subset, located between Tn and Tcm. Surface antigen analysis and differentiation assay showed that the flexibility of polarity and the cytokine production progressively changed as the differentiation of CD4+ T cells advanced. Interestingly, we found that most cells of the CD45RO-CCR7+CCR6+ subset, hitherto considered the na{\"i}ve precursor of Th17, were in fact Tscm. These findings may advance our understanding of the highly heterogeneous human helper T cells.",
keywords = "Helper T cell, Stem cell memory T, Th17 precursor",
author = "Masaru Takeshita and Katsuya Suzuki and Yoshiaki Kassai and Maiko Takiguchi and Yusuke Nakayama and Yuki Otomo and Rimpei Morita and Takahiro Miyazaki and Akihiko Yoshimura and Tsutomu Takeuchi",
note = "Funding Information: Yoshiaki Kassai, Maiko Takiguchi, Yusuke Nakayama, and Takahiro Miyazaki are employed by Takeda Pharmaceutical Company Limited. Tsutomu Takeuchi has received grants from Chugai Pharmaceutical Co. Ltd., Pfizer Japan Inc ., and Takeda Pharmaceutical Co. Ltd . Tsutomu Takeuchi has received income from AbbVie GK., Asahi Kasei Medical K.K., Astellas Pharma Inc., Astra Zeneca K.K., Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Novartis Pharma K.K., Pfizer Japan Inc., and Takeda Pharmaceutical Co. Ltd. Funding Information: This work was partly supported by Takeda Pharmaceutical Company Limited, Kanagawa, Japan (grant number 04-078-0067 ). Publisher Copyright: {\textcopyright} 2015 Elsevier Inc. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2015",
month = jul,
day = "1",
doi = "10.1016/j.clim.2015.04.010",
language = "English",
volume = "159",
pages = "107--117",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",
}